Introduction:Basic information about CAS 112093-28-4|Endoxifen (Z-isomer), including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Endoxifen (Z-isomer) |
|---|
| CAS Number | 112093-28-4 | Molecular Weight | 373.48700 |
|---|
| Density | 1.099g/cm3 | Boiling Point | 519.327ºC at 760 mmHg |
|---|
| Molecular Formula | C25H27NO2 | Melting Point | 127-129°C |
|---|
| MSDS | USA | Flash Point | 267.88ºC |
|---|
| Symbol | GHS09 | Signal Word | Warning |
|---|
Names
| Name | 4-[(Z)-1-[4-[2-(methylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol |
|---|
| Synonym | More Synonyms |
|---|
Endoxifen (Z-isomer) BiologicalActivity
| Description | Endoxifen Z-isomer is the most important Tamoxifen metabolite responsible for eliciting the anti-estrogenic effects of this drug in breast cancer cells expressing estrogen receptor-alpha (ERα). Endoxifen inhibits hERG tail currents at 50 mV in a concentration-dependent manner with IC50 values of 1.6 μM.IC50 value: 1.6 μM [1]Target: hERG Potassium Channel, Estrogen Receptor/ERREndoxifen Z-isomer is considered a prodrug, since it has a much higher potency for the estrogen receptor than its parent drug. Endoxifen inhibits the hERG channel protein trafficking to the plasma membrane in a concentration-dependent manner with Endoxifen being more potent than Tamoxifen. [1] Endoxifen is also shown to be a more potent inhibitor of estrogen target genes when ERβ is expressed. Additionally, low concentrations of Endoxifen Z-isomer observed in Tamoxifen treated patients with deficient CYP2D6 activity (20 to 40 nM) markedly inhibit estrogen-induced cell proliferation rates in the presence of ERβ, whereas much higher Endoxifen Z-isomer concentrations are needed when ERβ is absent.[2] |
|---|
| Related Catalog | Signaling Pathways >>Others >>Estrogen Receptor/ERRSignaling Pathways >>Membrane Transporter/Ion Channel >>Potassium ChannelResearch Areas >>Cancer |
|---|
| References | [1]. Chae YJ, et al. Endoxifen, the active metabolite of tamoxifen, inhibits cloned hERG potassium channels. Eur J Pharmacol. 2015 Apr 5;752:1-7. [2]. Wu X, et al. Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen. Breast Cancer Res. 2011 Mar 10;13(2):R27. |
|---|
Chemical & Physical Properties
| Density | 1.099g/cm3 |
|---|
| Boiling Point | 519.327ºC at 760 mmHg |
|---|
| Melting Point | 127-129°C |
|---|
| Molecular Formula | C25H27NO2 |
|---|
| Molecular Weight | 373.48700 |
|---|
| Flash Point | 267.88ºC |
|---|
| Exact Mass | 373.20400 |
|---|
| PSA | 41.49000 |
|---|
| LogP | 5.75040 |
|---|
| Vapour Pressure | 0mmHg at 25°C |
|---|
| Index of Refraction | 1.599 |
|---|
| InChIKey | MHJBZVSGOZTKRH-IZHYLOQSSA-N |
|---|
| SMILES | CCC(=C(c1ccc(O)cc1)c1ccc(OCCNC)cc1)c1ccccc1 |
|---|
| Storage condition | Amber Vial, -86°C Freezer, Under Inert Atmosphere |
|---|
Safety Information
| Symbol | GHS09 |
|---|
| Signal Word | Warning |
|---|
| Hazard Statements | H400 |
|---|
| Precautionary Statements | P273-P391 |
|---|
| RIDADR | UN 3077 9 / PGIII |
|---|
| RTECS | SL8285000 |
|---|
Synonyms
| Z-Endoxifen |
| 4OHNDtam |
| 4-Hydroxy-N-desmethyltamoxifen |
| Endoxifen |
| UNII-46AF8680RC |
| Endoxifen (Z-isomer) |